ImmuPharma (LON:IMM) Shares Up 34.1% - Here's What Happened

Key Points

• ImmuPharma's stock price rose by 34.1% during trading on Wednesday, reaching a high of GBX 11.50 ($0.16) after closing the previous day at GBX 8.06 ($0.11).
• The company has a market capitalization of £62.07 million and reported a net margin of 3,519.56% along with a negative return on equity of 131.41% in its latest earnings release.
• ImmuPharma specializes in peptide-based therapeutics for autoimmune diseases, focusing on its lead program, Lupuzor™, which targets treatment for Lupus and related conditions.

Shares of ImmuPharma plc (LON:IMM - Get Free Report) shot up 34.1% during mid-day trading on Wednesday . The stock traded as high as GBX 11.50 ($0.16) and last traded at GBX 10.81 ($0.15). 57,593,953 shares traded hands during trading, an increase of 656% from the average session volume of 7,620,919 shares. The stock had previously closed at GBX 8.06 ($0.11).

ImmuPharma Trading Up 28.8%

The firm has a market capitalization of £69.86 million, a price-to-earnings ratio of -1,570.67 and a beta of 1.53. The company has a 50-day moving average of GBX 3.12 and a 200-day moving average of GBX 2.92.

ImmuPharma (LON:IMM - Get Free Report) last issued its earnings results on Wednesday, August 6th. The company reported GBX (0.38) earnings per share for the quarter. ImmuPharma had a negative return on equity of 131.41% and a net margin of 3,519.56%. On average, research analysts forecast that ImmuPharma plc will post -339.0000022 earnings per share for the current year.

ImmuPharma Company Profile

ImmuPharma PLC LSE AIM: IMM is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company's portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.